SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-044827
Filing Date
2021-02-16
Accepted
2021-02-16 16:02:55
Documents
1
Group Members
CARL D. SODERSTROMCLAY M. HEIGHTEN, M.D.GILBERT G. GARCIA IIGPG LPI INVESTMENT, LLCGREEN PARK & GOLF VENTURES II, LLCHEALTH WILDCATTERS FUND II, LLCHEALTH WILDCATTERS, LLCLANTERN 3-19 INVESTMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d347206dsc13g.htm SC 13G 213395
  Complete submission text file 0001193125-21-044827.txt   215321
Mailing Address 5910 N. CENTRAL EXPRESSWAY, SUITE 200 DALLAS TX 75206
Business Address 5910 N. CENTRAL EXPRESSWAY, SUITE 200 DALLAS TX 75206 214-916-5750
Green Park & Golf Ventures, LLC (Filed by) CIK: 0001598984 (see all company filings)

IRS No.: 451783209 | State of Incorp.: TX | Fiscal Year End: 1214
Type: SC 13G

Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Subject) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91536 | Film No.: 21637897
SIC: 2834 Pharmaceutical Preparations